Ionis Pharmaceuticals (IONS) Earnings Date, Estimates & Call Transcripts → Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (From Priority Gold) (Ad) Free IONS Stock Alerts $40.39 -0.54 (-1.32%) (As of 03:27 PM ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Earnings SummaryUpcoming Earnings DateAug. 14EstimatedActual EPS (May. 7) -$0.98 Beat By $0.12 Consensus EPS (May. 7) -$1.10 Listen to Call Get Ionis Pharmaceuticals Earnings AlertsEnter your email address below to receive the latest news and earnings results for IONS and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueIONS Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.IONS Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Crypto 101 MediaTech GIANT’s Plans to Revolutionize Crypto…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. Ionis Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20243($0.85)($0.72)($0.80) Q2 20243($1.05)($0.82)($0.96) Q3 20243($1.04)($0.89)($0.97) Q4 20243($1.15)($0.58)($0.90) FY 202412($4.09)($3.01)($3.63) Q1 20251($1.13)($1.13)($1.13) Q2 20251($0.95)($0.95)($0.95) Q3 20251($0.93)($0.93)($0.93) IONS Earnings Date and InformationIonis Pharmaceuticals last announced its earnings results on May 7th, 2024. The reported ($0.98) EPS for the quarter, topping the consensus estimate of ($1.10) by $0.12. The company had revenue of $119 million for the quarter, compared to analyst estimates of $131.42 million. Its quarterly revenue was down 9.2% on a year-over-year basis. Ionis Pharmaceuticals has generated ($2.56) earnings per share over the last year (($2.56) diluted earnings per share). Earnings for Ionis Pharmaceuticals are expected to grow in the coming year, from ($3.76) to ($3.22) per share. Ionis Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 14th, 2024 based off prior year's report dates.Read More Ionis Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 8/14/2024Estimated)------- 5/7/2024Q1 2024($1.10)($0.98)+$0.12($0.98)$131.42 million$119.00 million 2/21/2024Q4 2023($0.78)($0.06)+$0.72($0.06)$176.01 million$325.00 million 11/2/2023Q3 2023($1.01)($1.03)($0.02)($1.03)$139.42 million$144.00 million8/9/2023Q2 2023($0.94)$0.60+$1.54$0.60$136.84 million$188.00 million 5/3/2023Q1 2023($1.00)($0.87)+$0.13($0.87)$126.88 million$131.00 million 2/22/2023Q4 2022($1.06)($0.37)+$0.69($0.37)$160.21 million$152.00 million Get the Latest News and Ratings for IONS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Ionis Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 11/9/2022Q3 2022($0.74)($0.33)+$0.41($0.33)$149.48 million$160.00 million8/9/2022Q2 2022($0.61)($0.74)($0.13)($0.74)$142.65 million$134.00 million 5/4/2022Q1 2022($0.68)($0.46)+$0.22($0.46)$122.46 million$142.00 million 2/24/2022Q4 2021$0.80$1.41+$0.61$1.41$284.08 million$440.00 million 11/3/2021Q3 2021($0.53)($0.58)($0.05)($0.58)$162.01 million$133.00 million 8/4/2021Q2 2021($0.56)($0.57)($0.01)($0.57)$128.46 million$126.00 million Ionis Pharmaceuticals Earnings - Frequently Asked Questions When is Ionis Pharmaceuticals's earnings date? Ionis Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 14th, 2024 based off last year's report dates. Learn more on IONS's earnings history. Did Ionis Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, Ionis Pharmaceuticals (NASDAQ:IONS) reported ($0.98) earnings per share (EPS) to beat the analysts' consensus estimate of ($1.10) by $0.12. Learn more on analysts' earnings estimate vs. IONS's actual earnings. How can I listen to Ionis Pharmaceuticals's earnings conference call? The conference call for Ionis Pharmaceuticals's latest earnings report can be listened to online. Listen to Conference Call How much revenue does Ionis Pharmaceuticals generate each year? Ionis Pharmaceuticals (NASDAQ:IONS) has a recorded annual revenue of $788 million. How much profit does Ionis Pharmaceuticals generate each year? Ionis Pharmaceuticals (NASDAQ:IONS) has a recorded net income of -$366.29 million. IONS has generated -$2.56 earnings per share over the last four quarters. What is Ionis Pharmaceuticals's EPS forecast for next year? Ionis Pharmaceuticals's earnings are expected to grow from ($3.76) per share to ($3.22) per share in the next year. More Earnings Resources from MarketBeat Related Companies: ALKS Earnings Date MDGL Earnings Date FOLD Earnings Date GERN Earnings Date UTHR Earnings Date BMRN Earnings Date TEVA Earnings Date ALNY Earnings Date CYTK Earnings Date BPMC Earnings Date Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Traders Sell but Investors Still Win After Palantir's EarningsTech Earnings Insights: Where Opportunity Meets UncertaintyApple’s Earnings Show Investors Its Strength and Its WeaknessCarvana’s Q1 Earnings: A Profitability U-TurnPayPal’s Strong Earnings Growth and Strategic Evolution GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future Outlook This page (NASDAQ:IONS) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersAI “wealth window” is closing June 25thParadigm PressElon Musk Secret Crypto Plot ExposedCrypto 101 MediaThe AI Stock that’s Disrupting Every IndustryStockEarningsShocking: One AI startup's revenue could surge 4,735%Manward PressForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill Publishing[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsCharles Payne Demystifies OptionsUnstoppable ProsperityWatch this FREE trading tutorial while it’s still availableInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ionis Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
